NCAM1 and neoplasm: Two inhibitors of NCAM polysialylation, low-molecular-weight heparin (LMWH) and cytidine monophosphate (CMP), have been proposed in drug research and have shown help in developments related to tumor-targeted polysialyltranseferases based on the above modulation model of NCAM polysialylation [16,23].